Arvee Laboratories (India) Ltd. (ARVEE) AI Stock Analysis

• Market Cap: ₹1.48B
• Dividend Yield: N/A
• Average Volume (3M): 1.40K
• Price to Earnings (P/E): 32.2
• Beta (1Y): 1.04
• Revenue Growth: -28.88%
• EPS Growth: -82.29%
• Country: IN
• Employees: 65
• Sector: Healthcare
• Sector Strength: 45
• Industry: Chemicals - Specialty
• EPS (TTM): 1.66
• Shares Outstanding: 11,020,000
• 10 Day Avg. Volume: 2,098
• 30 Day Avg. Volume: 1,398
• PEG Ratio: 0.72
• Price to Book (P/B): 5.18
• Price to Sales (P/S): 4.20
• P/FCF Ratio: -93.28
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 54 Neutral
• Price Target: ₹141.00 ▼(-41.81% Downside)
• Action: Reiterated Date: 03/25/26
• Date: Action: Reiterated 03/25/26

The score is primarily supported by a robust balance sheet, but is held back by weak cash generation and a clear bearish technical setup (below major moving averages with negative MACD). A relatively high P/E and no dividend further limit the attractiveness at the current price.

Positive Factors

Balance sheet strength

Conservative leverage and a strong equity ratio provide enduring financial stability, improving resilience to industry cycles and shocks. Positive ROE indicates shareholder profitability, supporting long-term access to capital and funding for strategic investments without excessive borrowing.

Negative Factors

Weak cash generation

Negative free cash flow and low operating cash flow to net income indicate challenges converting profits into cash. Over months this can constrain capital expenditures, R&D, or working capital needs, forcing external financing or reducing strategic flexibility.

Arvee Laboratories (India) Ltd. Business Overview & Revenue Model

Company Description

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid m...

Read more

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid m...

How the Company Makes Money

null...

Arvee Laboratories (India) Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2022
Income Statement
Total Revenue	353.65M	384.87M	303.42M	612.76M	403.27M	471.44M
Gross Profit	159.88M	121.63M	41.49M	173.09M	138.08M	142.99M
EBITDA	31.37M	42.69M	35.78M	86.34M	61.90M	61.30M
Net Income	13.74M	21.47M	10.52M	41.19M	25.74M	26.77M
Balance Sheet
Total Assets	0.00	381.58M	381.99M	386.85M	386.85M	410.46M
Cash, Cash Equivalents and Short-Term Investments	59.75M	49.06M	18.65M	8.92M	31.08M	86.39M
Total Debt	0.00	10.33M	10.00M	10.00M	31.31M	88.79M
Total Liabilities	-312.61M	68.97M	90.85M	106.23M	147.43M	196.08M
Stockholders Equity	312.61M	312.61M	291.14M	280.62M	239.42M	214.38M
Cash Flow
Free Cash Flow	0.00	-17.35M	10.78M	14.45M	16.52M	-5.80M
Operating Cash Flow	0.00	1.19M	36.64M	29.29M	40.16M	17.11M
Investing Cash Flow	0.00	-17.91M	-21.63M	-12.58M	592.61K	-6.04M
Financing Cash Flow	0.00	333.00K	-1.88M	-24.17M	-60.51M	45.20M

Arvee Laboratories (India) Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 242.32
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ARVEE, the sentiment is Negative. The current price of 242.32 is above the 20-day moving average (MA) of 149.71, above the 50-day MA of 157.09, and above the 200-day MA of 171.54, indicating a bearish trend. The MACD of -6.24 indicates Positive momentum. The RSI at 34.54 is Neutral, neither overbought nor oversold. The STOCH value of 5.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ARVEE.

Arvee Laboratories (India) Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BIOFILCHEM	63 Neutral	₹456.15M	172.45	―	―	36.76%	433.63%
BALAXI	62 Neutral	₹909.82M	111.96	―	―	―	―
ARVEE	54 Neutral	₹1.48B	32.17	―	―	-28.88%	-82.29%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
LASA	45 Neutral	₹299.10M	-4.63	―	―	-20.40%	-59.20%
VIVIMEDLAB	39 Underperform	₹458.51M	-2.21	―	―	-22.42%	21.83%

Arvee Laboratories (India) Ltd. Corporate Events